A High-Throughput Assay for DNA Replication Inhibitors Based upon Multivariate Analysis of Yeast Growth Kinetics

• Published in: SLAS discovery 2019-07, Vol.24 (6), p.669-681
• Main Authors: Ngo, Marilyn, Wechter, Nick, Tsai, Emily, Shun, Tong Ying, Gough, Albert, Schurdak, Mark E., Schwacha, Anthony, Vogt, Andreas
• Format: Article
• Language: English
• Subjects: Alleles; DNA Replication - drug effects; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical - methods; High-Throughput Screening Assays - methods; Reproducibility of Results; Synthetic Lethal Mutations; Yeasts - drug effects; Yeasts - genetics; Yeasts - growth & development
• ISSN: 2472-5552; 2472-5560
• DOI: 10.1177/2472555219829740

Mcm2–7 is the molecular motor of eukaryotic replicative helicase, and the regulation of this complex is a major focus of cellular S-phase regulation. Despite its cellular importance, few small-molecule inhibitors of this complex are known. Based upon our genetic analysis of synthetic growth defects between mcm alleles and a range of other alleles, we have developed a high-throughput screening (HTS) assay using a well-characterized mcm mutant (containing the mcm2DENQ allele) to identify small molecules that replicate such synthetic growth defects. During assay development, we found that aphidicolin (inhibitor of DNA polymerase alpha) and XL413 (inhibitor of the DNA replication-dependent kinase CDC7) preferentially inhibited growth of the mcm2DENQ strain relative to the wild-type parental strain. However, as both strains demonstrated some degree of growth inhibition with these compounds, small and variable assay windows can result. To increase assay sensitivity and reproducibility, we developed a strategy combining the analysis of cell growth kinetics with linear discriminant analysis (LDA). We found that LDA greatly improved assay performance and captured a greater range of synthetic growth inhibition phenotypes, yielding a versatile analysis platform conforming to HTS requirements.